Advances in genetic testing and optimization of clinical management in children and adults with epilepsy

on the behalf of Genetic Commission of Italian League Against Epilepsy (LICE)

Research output: Contribution to journalReview article

Abstract

Introduction: Epileptic disorders are a heterogeneous group of medical conditions with epilepsy as the common denominator. Genetic causes, electro-clinical features, and management significantly vary according to the specific condition. Areas covered: Relevant diagnostic advances have been achieved thanks to the advent of Next Generation Sequencing (NGS)-based molecular techniques. These revolutionary tools allow to sequence all coding (whole exome sequencing, WES) and non-coding (whole genome sequencing, WGS) regions of human genome, with a potentially huge impact on patient care and scientific research. Expert opinion: The application of these tests in children and adults with epilepsy has led to the identification of new causative genes, widening the knowledge on the pathophysiology of epilepsy and resulting in therapeutic implications. This review will explore the most recent advancements in genetic testing and provide up-to-date approaches for the choice of the correct test in patients with epilepsy.

Original languageEnglish
JournalExpert Review of Neurotherapeutics
DOIs
Publication statusAccepted/In press - Jan 1 2020

Fingerprint

Genetic Testing
Epilepsy
Exome
Expert Testimony
Human Genome
Patient Care
Genome
Research
Genes
Therapeutics

Keywords

  • antiepileptic drugs
  • Epilepsy
  • genetic testing
  • next Generation Sequencing
  • surgery
  • therapy
  • whole Exome Sequencing

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Advances in genetic testing and optimization of clinical management in children and adults with epilepsy. / on the behalf of Genetic Commission of Italian League Against Epilepsy (LICE).

In: Expert Review of Neurotherapeutics, 01.01.2020.

Research output: Contribution to journalReview article

on the behalf of Genetic Commission of Italian League Against Epilepsy (LICE). / Advances in genetic testing and optimization of clinical management in children and adults with epilepsy. In: Expert Review of Neurotherapeutics. 2020.
@article{2b62a52497d34cafa167e7af5d3b1203,
title = "Advances in genetic testing and optimization of clinical management in children and adults with epilepsy",
abstract = "Introduction: Epileptic disorders are a heterogeneous group of medical conditions with epilepsy as the common denominator. Genetic causes, electro-clinical features, and management significantly vary according to the specific condition. Areas covered: Relevant diagnostic advances have been achieved thanks to the advent of Next Generation Sequencing (NGS)-based molecular techniques. These revolutionary tools allow to sequence all coding (whole exome sequencing, WES) and non-coding (whole genome sequencing, WGS) regions of human genome, with a potentially huge impact on patient care and scientific research. Expert opinion: The application of these tests in children and adults with epilepsy has led to the identification of new causative genes, widening the knowledge on the pathophysiology of epilepsy and resulting in therapeutic implications. This review will explore the most recent advancements in genetic testing and provide up-to-date approaches for the choice of the correct test in patients with epilepsy.",
keywords = "antiepileptic drugs, Epilepsy, genetic testing, next Generation Sequencing, surgery, therapy, whole Exome Sequencing",
author = "{on the behalf of Genetic Commission of Italian League Against Epilepsy (LICE)} and Marcello Scala and Amedeo Bianchi and Francesca Bisulli and Antonietta Coppola and Maurizio Elia and Marina Trivisano and Dario Pruna and Tommaso Pippucci and Laura Canafoglia and Simona Lattanzi and Silvana Franceschetti and Carlo Nobile and Antonio Gambardella and Roberto Michelucci and Federico Zara and Pasquale Striano",
year = "2020",
month = "1",
day = "1",
doi = "10.1080/14737175.2020.1713101",
language = "English",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",

}

TY - JOUR

T1 - Advances in genetic testing and optimization of clinical management in children and adults with epilepsy

AU - on the behalf of Genetic Commission of Italian League Against Epilepsy (LICE)

AU - Scala, Marcello

AU - Bianchi, Amedeo

AU - Bisulli, Francesca

AU - Coppola, Antonietta

AU - Elia, Maurizio

AU - Trivisano, Marina

AU - Pruna, Dario

AU - Pippucci, Tommaso

AU - Canafoglia, Laura

AU - Lattanzi, Simona

AU - Franceschetti, Silvana

AU - Nobile, Carlo

AU - Gambardella, Antonio

AU - Michelucci, Roberto

AU - Zara, Federico

AU - Striano, Pasquale

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Introduction: Epileptic disorders are a heterogeneous group of medical conditions with epilepsy as the common denominator. Genetic causes, electro-clinical features, and management significantly vary according to the specific condition. Areas covered: Relevant diagnostic advances have been achieved thanks to the advent of Next Generation Sequencing (NGS)-based molecular techniques. These revolutionary tools allow to sequence all coding (whole exome sequencing, WES) and non-coding (whole genome sequencing, WGS) regions of human genome, with a potentially huge impact on patient care and scientific research. Expert opinion: The application of these tests in children and adults with epilepsy has led to the identification of new causative genes, widening the knowledge on the pathophysiology of epilepsy and resulting in therapeutic implications. This review will explore the most recent advancements in genetic testing and provide up-to-date approaches for the choice of the correct test in patients with epilepsy.

AB - Introduction: Epileptic disorders are a heterogeneous group of medical conditions with epilepsy as the common denominator. Genetic causes, electro-clinical features, and management significantly vary according to the specific condition. Areas covered: Relevant diagnostic advances have been achieved thanks to the advent of Next Generation Sequencing (NGS)-based molecular techniques. These revolutionary tools allow to sequence all coding (whole exome sequencing, WES) and non-coding (whole genome sequencing, WGS) regions of human genome, with a potentially huge impact on patient care and scientific research. Expert opinion: The application of these tests in children and adults with epilepsy has led to the identification of new causative genes, widening the knowledge on the pathophysiology of epilepsy and resulting in therapeutic implications. This review will explore the most recent advancements in genetic testing and provide up-to-date approaches for the choice of the correct test in patients with epilepsy.

KW - antiepileptic drugs

KW - Epilepsy

KW - genetic testing

KW - next Generation Sequencing

KW - surgery

KW - therapy

KW - whole Exome Sequencing

UR - http://www.scopus.com/inward/record.url?scp=85078446587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078446587&partnerID=8YFLogxK

U2 - 10.1080/14737175.2020.1713101

DO - 10.1080/14737175.2020.1713101

M3 - Review article

AN - SCOPUS:85078446587

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

ER -